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Summary 
Follicular dendritic cells (FDC) are unique nonlymphoid cells found only in germinal centers. 
FDC can be distinguished from other accessory cells based on a characteristic set of cell surface 
markers. It is known that FDC are able to rescue germinal center B cells from apoptosis.  To 
investigate the role of FDC in the process of selection and maturation of B cells during germinal 
center reactions, we tried to establish factor-independent immortalized FDC-like cell lines. Because 
freshly isolated FDC express the Epstein-Barr Virus (EBV) receptor CD21, we attempted EBV 
transformation on isolated FDC. After incubation of FDC-enriched cell populations with EBV, 
cell lines were obtained consisting of slowly duplicating very large cells. These cell lines have 
a fibroblast-like morphology but could be clearly distinguished from several human fibroblast 
cell lines by displaying a different phenotype including intercellular adhesion molecule 1, CD40, 
and CD75 expression. Detection of the EBV-encoded proteins latent membrane protein 1 and 
Epstein-Barr virus  nuclear  antigen  2  in  our  FDC-like  cdl  lines  implicated  successful  EBV 
transformation. FDC-like cdls are able to bind nonautologous B cells and preserve the latter 
from apoptosis.  The binding orB cells to FDC-like cells is dependent on adhesion via lymphocyte 
function-associated antigen 1/interceLlular  adhesion molecule 1 and closely resembles the pattern 
of emperipolesis as described by others. These data demonstrate that FDC can be successfully 
infected by EBV  and that the cell lines obtained share phenotypic and functional characteristics 
with freshly isolated FDC. 
G 
erminal centers of lymphoid follicles are microenviron- 
ments where mature B lymphocytes localize, proliferate, 
and differentiate into memory B cells or into Ig-producing 
cells.  Within  germinal  centers  follicular  dendritic  cells 
(FDC) 1 are found in close contact with B cells (reviewed in 
references 1-4). FDC are unique nonlymphoid cells only found 
in germinal centers. Their long dendritic processes  form a 
fine network that is intimately associated with B lympho- 
cytes. FDC can be distinguished from other accessory cells 
in secondary lymphoid tissues based on several features, in- 
cluding lack of phagocytotic activity, and a characteristic set 
of cell surface markers, such as receptors for complement C3 
fragments and adhesion molecules (5-12).  It was recently 
shown that FDC are able to rescue germinal center B cells 
from apoptosis by a cell-cell contact-dependent mechanism 
1 Abbreviations used in this paper: EBNA-2,  Epstein-Barr  virus  nuclear 
antigen 2; FDC, follicular dendritic cell(s); FLCL, FDC-like cell line(s); 
ICAM-1,  intercellular  adhesion  molecule  1;  IMDM/g,  IMDM  with 
gentamidn; LMP-1, latent membrane protein 1; SAC, Staphylococcus  aureus 
Cowan I; VCAM, vascular cell adhesion molecule 1. 
(13). To facilitate the study of the role of FDC in the process 
of B cell selection and maturation during germinal center 
reactions it would be important to establish FDC cell lines 
for use in in vitro experiments. Although Tsunoda et al. (14) 
have reported that long-term culture of FDC was feasible, 
these cells did not divide in vitro. In addition, several other 
investigators have reported on malignant FDC-like tumors 
but they were not able to establish  cell lines from these pa- 
tients (15-17). Kecently, Clark et al. (18) reported that they 
were able to culture FDC-like cells in vitro. These cells were 
not immortalized or transformed and the proliferation of these 
cells was dependent on GM-CSF. Alternatively, in this ar- 
ticle we report on the establishment of immortalized foUic- 
ular dendritic cell-like cell lines (FILL) obtained by EBV trans- 
formation of FDC-enriched cell populations. These cell lines 
proliferate independent of growth factors and share pheno- 
typic and functional properties with freshly isolated FDC. 
Materials and Methods 
Isolation of  FDC.  FDC were isolated as described  by Parmentier 
et al. (8). In brief, tonsils, freshly obtained from children under- 
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were incubated twice for 30 min at 37~  under continuous shaking 
in 30 ml of IMDM plus 90/~g/ml gentamicin (IMDM/g) con- 
taining 200 U/ml collagenase  type IV (Worthington Biochemical 
Corp., Freehold, NJ) and 10 U/ml DNase I (Boehringer Mann- 
helm GmbH, Mannheim, Germany). Next, the cell suspensions 
were cooled on ice and centrifuged for 10 min at 600 g. The pellets 
were resuspended in IMDM/g and subjected to 1 g sedimentation 
(30 rain, 0~  in discontinuous BSA gradients consisting of layers 
of 1.5%, 2.5%, and 5% BSA in HBSS. Cells at the interfaces  be- 
tween 2.5 and 5% BSA were collected, washed, and layered on 
Percoll gradients (Pharmacia, Uppsah, Sweden), consisting  of  layers 
with densities of 1,070, 1,060, and 1,030 mg/ml, and centrifuged 
for 20 min at 1,200 g. Cells with densities of <1,060 mg/ml were 
collected. These FDC-enriched cell suspensions were used for fur- 
ther experiments and contained 5-20%  DRC-l-positive  cells. 
EBV Transformation.  EBV containing supernatant  from the mar- 
moset B95.8 cell line (19) was added (10% vol/vol) to 5  x  106 
cells from FDC-enriched cell suspensions and incubated at 37~ 
and 5% CO2. After 24 h the cells were harvested, washed, and 
brought into culture in IMDM/g plus 10% FCS in six-well cul- 
ture plates (Costar, Cambridg~ MA). After I wk nonadhering  EBV- 
transformed B cells were removed by repeated thorough washing 
with IMDM/g. In some experiments the FDC-enriched cell popu- 
lations were depleted  of  LFA-l-positive  cells  before transformation. 
This depletion was done by incubation with anfi-LFA-1  antibodies 
(Table 1) and subsequent incubation with Dynabeads coated with 
goat anti-mouse-Ig (Dynal, Oslo, Norway). 
Immunophenotyping.  FDC-like  cells  were harvested  by incubating 
with 0.25% trypsin solution (GIBCO, Paisley,  Scotland) for 5-10 
rain at 37~  Immunophenotyping of surface markers was done 
by indirect staining with a number of mAbs (Table 1) and a FITC- 
conjugated F(ab')2-rabbit anti-mouse Ig (Zymed, San Francisco, 
CA). 5 x  103 cells per sample were analyzed using a FACScan  4  | 
cytofluorometer (Becton Dickinson & Co., Mountain View, CA). 
For cytoplasmic  markers, immunophenotyping  was done by indirect 
staining of cytospin preparations; 2  x  104 cells were spun onto 
glass slides using a cyto-centrifuge  (Shandon  Inc., Pittsburgh, PA). 
Cytospin preparations were incubated  for 60 rain with mAbs (Table 
1) or isotype-matched control Igs followed by HTC-cunjugated 
or PE-conjugated F(ab')2-rabbit anti-mouse Ig (Zymed) for fluo- 
rescence microscopy or horseradish peroxidase-conjugated rabbit 
anti-mouse Ig (Dakopatts, Glostrup, Denmark). Peroxidase  activity 
was visualized by incubation with the substrate 3-amino-9-ethyl- 
carbazole (Sigma Chemical Co., St. Louis, MO) in acetate buffer 
pH 4.9 for 30 rain at room temperature. Cells in these prepara- 
tions were counterstained with hematoxylin. 
The reexpression of HLA-DR and vascular cell adhesion mole- 
cule 1 (u  was studied after preincubation with 100 U/ml 
recombinant human (rh) ID4 (DNAX,  Palo Alto, CA) for 24 h 
followed by FACScan  |  or cytospin labeling. As controls in these 
experiments, the human fibmblastic  cell  lines  HFB-VH, HSF-7 (fore- 
skin derived), HFC, Hengelmolen  (skin derived), and NN310 (tonsil 
derived) were used. 
Cloning of FDC-lilee Cell Lines.  After at least 3 wk of culture 
and immunophenotyping, FLCL were cloned by limiting dilution. 
The cells were harvested and subsequently cultured at 10, 3, or 
I cell per well in 96-well plates in IMDM/g plus 10% FCS or in 
IMDM/g plus 10% FCS with the addition of 100 U/ml GM-CSF 
(Genzyme  Corp., Boston, MA), supematant from cultures of  FLCL 
(10% vol/vol) or a mixture of supematants from JY and Raji cells 
(i.e., 25% vol/vol)JY supematant and 25% vol/vol Raji superna- 
tant) (20). Wells showing cell growth were counted after 2-4 wk. 
Adherence of  B Cells to Cultured  FDC Lines.  FLCL  or fibroblasts 
were harvested, resuspended, and seeded  into six-well  culture plates 
(Costar) in IMDM/g plus 10% FCS. 2.5 -5  x  103 FLCL or 2 
x  104 fibrobhsts were seeded into each well. Low-density and 
high-density B call fractions were obtained by centrifugation (15 
min, 1,200g, 4~  of purified tonsillar B cells on a Pereoll (Phar- 
macia, Uppsala, Sweden)  gradient, consisting of four density hyers 
(1,077/1,067/1,056/1,043 mg/ml). Cells at the 1,043/1,056 inter- 
face (low-density  cells) and at the 1,067/1,077 interface (high-density 
cells) were used. The low-density B cell fraction mainly consisted 
of germinal center B cells (+70%  CD38 +,  _+20% slgD + and 
CD39+); the high-density B cell fraction was enriched for mantle 
zone  B  cells (50% sIgD +  and  CD39 +,  40%  CD38§  For 
blocking experiments, the B cells were incubated for 30 min with 
anti-LFA-1 antibodies before culture. After 24 h of culture of the 
FLCL or fibroblasts, 0.5-2  x  10  ~ freshly isolated tonsillar low- 
density or high-density B cells were added to the culture wells and 
incubated  at 37~  for another 18 h. Subsequently  the cultures were 
stained for 1 h at 37~  with 25/zg/ml of  the fluorescent  dye Hoechst 
33258 (Sigma Chemical Co.) as described previously (13). Next, 
a cover glass (24  x  24 ram) was lowered into the well and excess 
culture medium was removed. The cell cultures were examined 
directly in their culture wells using a Leitz Orthoplan fluorescence 
microscope (E. Laitz, Wetzland, Germany) with Ploem Opak illu- 
mination. An NPL 25 x/0.75 and a NPL 50x/1.00 oil immersion 
objective were routinely used. 
Influence of Cultured FDC-Iilee Cell Lines or FLCL Culture Super- 
natant on B Cell Proliferation.  FLCL were harvested, resuspended, 
and seeded  at 100-500 cells  per well in 96-w~11 culture phtes (Costar) 
in IMDM/g plus 10% FCS and cultured for 24 h at 37~  Next, 
2  x  104 freshly isohted tonsillar B lymphocytes  were added in the 
presence or absence of immobilized anti-IgM antibodies (Im- 
munobeads, 5 #g/ml; Bio-rad Laboratories, Richmond, CA) and 
100 U/ml rhlL-2 (generous  gift ofEurocetus BV., Amsterdam, The 
Netherlands) or 100 U/ml rhIL-4 (DNAX) or in the presence of 
Staphy~occus aureus Cowan strain I (SAC, 1:10,000, Pansorbin, Cal- 
biochem Corp., La Jolla, CA) and 100 U/ml rhIL-2. After 48 h 
of culture at 37~  0.3 #Ci [3H]thymidine (Amersham Interna- 
tional, Amersham, UK) per well was added to the cultures and 
they were further incubated for 18 h. Cells were harvested onto 
glass fiber ~ters using a cell harvester (Titertek, Skatron, Lierbyen, 
Norway). Incorporation of [3H]thymidine was assessed using an 
LKB-Wallac  liquid scintillation  counter (Bromma, Sweden) and the 
data were expressed as counts per minute. To study the effect of 
FLCL supernatant on B cell proliferation, FLCL culture superna- 
tants were collected after 3 d of culturing FLCL in tissue culture 
flasks. The influence on B cell proliferation was assessed by stimu- 
lation of B cells, as described above, in the presence or absence of 
50% vol/vol of FLCL culture supernatant. 
Results 
Infection of FDC with EBV Results in Continuous Prolifera- 
tion of  FDC.  After infection with EBV, large adherent and 
slowly duplicating cells were obtained (Fig.  1).  These cell 
cultures also contained EBV-transformed B calls, which could 
be largely removed by extensive washing of the culture wells. 
Depletion of LFA-l-positive cells before EBV infection, how- 
ever, reduced the number of accompanying EBV-transformed 
B cells to a minimum. 
After about 3 wk of culture, the cells were immunopheno- 
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In contrast to freshly  isohted FDC, all EBV-transformed  FDC- 
like cell lines expressed  the EBV-encoded  antigens latent mem- 
brane protein 1 (LMP-1), Epstein-Barr virus nuclear antigen 
2 (EBNA-2) (Fig. 2), and the protein BCL-2 (data not shown), 
which is upregulated  after EBV transformation (21), indi- 
cating the establishment of stable EBV-transformed FDC. 
The staining pattern of EBNA-2 closely resembles the pat- 
tern of EBNA-2 expression in EBV-transformed B cell lines 
as described by Young et al. (22), i.e., a characteristic granular 
labeling of the nuclei with unstained nucleoli. The expres- 
sion of Ki-67 could only be detected in a small percentage 
of FI.CL (data not shown). 
The phenotype of the proliferating  cells was studied by 
FACScan  |  (for membrane markers) or staining of cytospin 
preparations (for intracellular markers) using a panel of mAbs 
(Table 1). FLCL  demonstrated high intercellular adhesion mol- 
ecuh 1 (ICAM-1) and gp93 expression  and expression  of  CD40 
and CD75 (Fig. 3). CD40 is a 44-48-kD integral membrane 
protein sharing structural homology with NGF-K, TNF-K, 
Table  1.  Antibodies Used 
mAb  Marker/Isotype  Source 
T cell associated 
OKT3  CD3/IgG2a 
B cell associated 
B1  CD20/IgG2a 
BU32  CD21(CK2,C3dr)/IgG1 
IOBla  CD21(CR2,C3dr)/IgG1 
MHM6  CD23/IgG1 
$2C6  CD40/IgG1 
EBU141  CD75/IgM 
Adhesion molecules 
CLB-LFA1/2  CD11a(LFA-l,oO)/IgG1 
HP 2/1  CD49d(VLA-4,ot4)/IgG1 
K/R-1  CD54(ICAM-1)/IgG1 
4B9  VCAM-1/IgG1 
Myeloid associated 
CLB44  CDllb(CR3,C3bi)/IgM 
LeuM3  CD14/IgG2b 
2E1  CDw32(Fc3,KII)/IgG2a 
D3  CD35(CR1,C3b)/IgG1 
CLB-FcKgr  CD16(Fc'yRIII)/IgG2a 
FDC associated 
12B1  FDC(gp93)/IgG2a 
DR.C- 1  FDC/IgM 
BU30*  FDC/IgG 
Nonlineage 
2D1  CD45(HLe-1)/IgG1 
JC/70A  CD31/IgG1 
F8/86  Factor VIII/IgG1 
B8.12.2  HLA-DR/IgG2b 
124  BCL-2/IgG1 
Ki67  Nuclear antigen/IgG1 
Csl-4  LMP-1/IgG1 
PE2  EBNA-2/IgG1 
MAS-516  Human fibroblast/IgM 
Ortho,  Raritan, NJ 
Coulter Corp., Hialeah, FL 
Binding Site, Birmingham, UK 
Immunotech, Luminy, France 
Dakopatts, Glostrup, Denmark 
Gift from Dr. S. Panli, Stockholm, Sweden 
Gift from Dr. M. Gramatzki, Erlangen, Germany 
Gift from Dr. R. van Lier, CLB, Amsterdam 
Immunotech, Luminy, France 
Gift from Dr. T. Springer, Boston, MA 
Gift from Dr. J. Harlan, Seattle, WA 
CLB, Amsterdam, The Netherlands 
Becton Dickinson, Mountain View, CA 
Immunotech, Luminy, France 
Gift from Prof. M. Daha, Leiden, The Netherlands 
CLB, Amsterdam, The Netherlands 
Immunotech, Luminy, France 
Dakopatts, Glostrup, Denmark 
Gift from Dr. G. Johnson, Birmingham, UK 
Becton Dickinson, Mountain View, CA 
Dakopatts, Glostmp, Denmark 
Dakopatts, Glostrup, Denmark 
Immunotech, Luminy, France 
Gift from Dr. D.Y. Mason, Oxford, UK 
Dakopatts, Glostrup, Denmark 
Dakopatts, Glostrup, Denmark 
Dakopatts, Glostrup, Denmark 
Sera-Lab, Crawley  Down, Sussex, UK 
" Not FDC specific. Also, some reaction  with follicular mantle B cells and smooth muscle  cells but not reactive  with human fibroblasts. 
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processes and nudei with dear nucleoli,  x 120; bar, 0.1 mm. 
CD27,  and Fas  antigen  (23,  24)  and is important  in  the 
proliferation and differentiation of B cells (25).  CD75  is a 
cell surface carbohydrate antigen on a glycolipid and its for- 
mation is dependent of a a2-6  sialyltransferase  (26-29).  It 
is highly expressed on activated B cells. The functions of these 
molecules on FDC  are presently unknown.  Furthermore, 
FLCL did not express CD3, CD20, LFA-1, or VLA-4, indi- 
cating that these cell lines are not T  cell or B cell derived. 
Also, CD45 is not found on FLCL, in line with recent reports 
describing that freshly isolated FDC do not express CD45 
or contain CD45 mRNA (11). This supports the idea that 
the FLCL are not bone marrow derived. These FLCL did 
not express endothelial cell markers CD31 or factor VIII (von 
Willebrand factor). 
Although FLCL shared some morphological details with 
human fibroblasts, the phenotype of FLCL indicated that these 
cells are FDC derived. The labeling for FDC-related markers 
DRC-1 and BU30 showed that these markers are present on 
freshly isolated FDC but disappear after 2-3 wk in culture. 
These data are in line with reports from other groups who 
also could not detect DRC-1 expression after prolonged cul- 
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ture of FDC (14, 18, 30). The FLCL did not express CD21 
and HLA-DR, previously reported to be present on freshly 
isolated human FDC but lost after short periods of culture 
(14).  VCAM-1  expression, also  present on freshly isolated 
FDC (18, 31), could not be found on cultured FLCL. Incu- 
bation of FLCL for 24 h  with  100  U/ml rhlL-4,  resulted 
in upregulation of  VCAM-1 expression which is in line with 
the data of Clark et al. (18), but not in reexpression of HLA- 
DR (Fig. 4). In contrast to Clark et al. (18) and to Tsunoda 
et al. (14), we did not find upregulation of HLA-DR after 
incubation of FLCL with 100 U/ml IFN-'y (data not shown). 
Cloning of  FDC-like Cell Lines.  FLCL were cloned by cul- 
turing in limiting dilution; 2-3 wk after cloning, the number 
of wells with growing FLCL were scored. Cloning in cul- 
ture  medium  or  in  the  presence  of GM-CSF  or  FLCI: 
conditioned medium resulted in poor cloning efficiency. In 
contrast, high cloning efficiency  could be seen when cloning 
was  performed  in  the  presence  of  Raji/JY-conditioned 
medium. The comparative data of three experiments with 
different tonsils are given in Table 2.  In subsequent experi- 
ments cloning was performed only in the presence of RAJI/JY 
supernatant. To date, using this procedure, FDC-like cell lines 
from at least 25 different tonsil donors have successfully  been 
cloned and these clones are now growing in vitro for periods 
up to 8 mo. The highest proliferation rate is maintained when 
these clones  remain cultured in  the presence of Raji/JY- 
supematant. After doning, individual FLCL dones were tested 
for phenotypic and functional characteristics.  The phenotype 
of individual clones was the same as was reported for the 
parental cell lines as is  summarized in Table 3. 
Functional Capacities of Cloned, EBV-transformed  FDC-like 
Cell Lines.  Freshly isolated nonautologous tonsil low-density 
or high-density B cells rapidly adhered to cloned FLCL upon 
co-culture (Fig. 5). Our observations suggest an intimate cel- 
lular contact between FLCL and B cells. This is in line with 
previous observations done by our group and by others for 
in vitro culture of freshly isolated FDC and B cells (13,  14, 
32). The percentage of adherent B cells was considerably higher 
with low-density B cells in comparison with high-density 
B cells. The binding of B cells to FLCL could be prevented 
by the addition of antibodies against the adhesion molecule 
LFA-1  (Table 4). Staining of these cultures after 18 h with 
Hoechst 33258 revealed that cells adhering to cloned FLCL 
were viable, whereas B cells co-cultured with fibroblasts hardly 
made cell-cell contact to the latter,  and as a consequence, 
most B cells displayed an apoptotic  appearance (Table 4). 
When  freshly  isolated  FDC-enriched  cell  suspensions 
(_+ 10% FDC, 10% T cells and 80% B cells) were stimulated 
with immobilized anti-IgM or SAC and IL-2, B cell prolifer- 
ation was found to be decreased compared with FDC-depleted 
cell suspensions (Table 5). These data suggest an inhibiting 
effect of FDC on B cell proliferation.  In line with these results, 
it was also found that addition of 100-500 cloned FLCL to 
cultures of in vitro-stimulated nonautologous tonsillar B lym- 
phocytes resulted in decreased proliferation (Table 6).  The 
presence of 500 human fibroblasts  had no effect on B cell 
proliferation. Only with 104 human fibroblasts,  was a minor 
inhibiting effect on B cell proliferation observed. To deter- 
Follicular Dendritic Cells Figure 2.  Cytospin  preparations  of FLCL stained  with antibodies  against (a and b) EBNA-2  or (c and d) LMP-1. EBNA-2  staining: (a) phase-contrast 
picture; (b) fluorescence  picture  showing  staining of most nuclei  (note nonstained  nucleoli).  LMP-1 staining: (c) phase contrast  picture; (d) fluorescence 
picture showing staining of LMP-l-positive cells; note nonstained nuclei  (arrows).  x320. 
mine whether or not the observed inhibition of proliferation 
was cell-cell contact dependent or dependent on a soluble 
factor, we have investigated the influence of FLCL-culture 
supernatant on B cell proliferation. Under these conditions 
an inhibition of B cell proliferation was observed (Table 7), 
suggesting that part of the influence of  FI.CL on B cell prolif~- 
ation is mediated by soluble factors.  These results are in line 
with data from Freedman et al. (33) who also described inhi- 
bition of B cell proliferation by FDC or FDC-culture super- 
natants.  In contrast, the presence of human fibroblast cul- 
ture supernatant hardly influenced B  cell proliferation. 
Discussion 
FDC are thought to play a crucial role in the development 
of high-affinity B cells and memory B cell formation during 
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germinal center reactions. To study the exact nature of the 
functions of FDC in these processes we have attempted to 
immortalize FDC by EBV transformation of FDC-enriched 
cell suspensions. 
As far as we are aware, EBV infection of FDC  has  not 
been demonstrated before. Binding of EBV to CD21 (com- 
plement/EBV receptor) on B cells is mediated by the viral 
envelope glycoprotein, gp350/220 (34) through a peptide that 
is highly homologous to a portion of the C3dg ligand (35). 
Because fleshly isolated FDC express high amounts of CD21, 
FDC might very well be susceptible to infection by EBV. 
Expression in FLCL of the EBV-encoded proteins LMP-1, 
EBNA-2, and the protein BCL-2 upregulated by LMP-1 (21) 
after incubation with EBV-containing supernatant confirmed 
that FDC were effectively infected by EBV. 
Recently it was described by others that human epithelial COHTROL 
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Figure 3.  Histogram plots from FACScan  |  analysis  of representative FLCL. Conjugate control is printed in the top left graph and as a dotted line 
in panels with positive staining. Histograms are plotted as log fluorescence intensity (x-axis) vs. relative cell number (y-axis). 
Table  2.  Cloning of FCD-like Cell Lines 
Addition 
Experiment  Cells/well  Medium  GM-CSF  Raji/JY-sup  FLCL-sup 
1  1  0/24  0/24  5/24  0/24 
3  1/24  1/24  7/24  0/24 
10  7/24  3/24  21/24  7/24 
2  1  0/24  0/24  3/24  0/24 
3  0/24  0/24  10/24  1/24 
10  3/24  1/24  10/24  3/24 
3  1  0/24  1/24  0/24  0/24 
3  1/24  0/24  5/24  1/24 
10  6/24  2/24  8/24  7/24 
Data are represented as number of wells with growth per number of wells seeded. 
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Figure 4.  Histogram plots from Faescan 
analysis after incubation with rhlL4 of (a) 
FLCL  labeled  with  antibodies  against 
VCAM-1,  (b)  human  fibroblasts  labeled 
with antibodies against VCAM-1, or (c) 
FLCL labeled with antibodies against HLA- 
DR.  Conjugate control is printed in the 
top graphs. Histograms are plotted as log 
fluorescence intensity (x-axis) vs. relative 
cell number (y-axis). 
tumor cell lines either expressing CD21 (36) or transfected 
with CD21 cDNA (37) could be infected by EBV and that 
occasionally replication of the virus was observed. Whether 
or not virus replication  occurs in  EBV-infected FLCL is 
presently unknown. 
The immortalized FLCL share morphologic characteris- 
tics with fibroblasts. They have dendritic processes and they 
are adherent to plastic. However, FLCL could be clearly dis- 
tinguished from fibroblasts by several characteristic features. 
First,  it appeared that FLCL proliferate very slowly (their 
duplication time is m3-7 d, whereas human fibroblastic cell 
lines used as controls proliferate  very rapidly. This slow prolifer- 
ation rate can correlate with the low percentage of Ki-67-posi- 
tive cells observed (_+ 10%). Ki-67 is only present from late 
G1 till M phase and is not present in the GO phase (38), indi- 
cating that only a small percentage of the cells is in cycle. 
FLCL appeared to display a unique FDC-like phenotype (Table 
3) clearly different from that of  five different established  human 
fibroblastic cell lines. The FLCL phenotype includes expres- 
sion of the adhesion molecule ICAM-1 (CD54) and of the 
B cell-related antigens CD40 and CD75. ICAM-1, CD40, 
and CD75, according to our observations and those of others 
(18, 39), are expressed by freshly isolated FDC but not by 
fibroblasts. Markers specific  for T cells (CD3, CDlla, CD49d), 
markers specific  for B cells (CD20, CD11a, CD49d), and the 
leukocyte common antigen CD45 were not expressed indi- 
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cating that  our FLCL  are  not  lymphocyte-derived cells. 
Markers for endothelial cells (CD31,  factor VIII) were not 
seen on these cells, indicating that they are not endothelial 
cell related. Typical FDC markers like DRC-1 were only ex- 
pressed during the first 2 wk of culture. This phenomenon 
was also described by other investigators (14, 18). Further- 
more, expression of VCAM-1 not found on FLCL could be 
induced on FLCL by incubation with rhlL-4 (Fig. 3), in line 
with the report of Clark et al. (18). In contrast to Clark et 
al., however, we could not induce expression of HLA-DR 
after incubation  with IFN-% 
Second, it could be demonstrated that FLCL display func- 
tional properties  that are characteristic for human FDC. It 
appeared that both low-density as well as high-density B cells 
adhere very rapidly to FLCL upon co-culture, whereas B cells 
hardly adhere to human fibroblasts in our experiments.  In 
general, the tendency of  low-density B cells to adhere to FLCL 
was two to three times higher than of high-density B cells. 
We observed that the adherence of B cells to FLCL was very 
intimate and closely resembled the pattern of emperipolesis 
described by others for both in vivo as well as in vitro studies 
(30, 32, 40) for the interaction of B cells and FDC. Our ob- 
servations however, do not allow definite conclusions about 
emperipolesis. The binding of B cells to FLCL was depen- 
dent on interaction between the adhesion molecules LFA-1 
on the B cells and ICAM-1 on the FLCL, because binding Table  3.  Imraunophenotyping of Cultured FDC-like Cells 
Antibody  Marker  FDC  FLCL  HFB  Antibody  Marker  FDC  FLCL  HFB 
T  cell  associated  FDC  associated 
OKT3  CD3  -  -  -  12B1  FDC  +  +  +  +  -+ 
B  ceU  associated  DRC-I*  FDC  +  +  _+/-  - 
B1  CD20  -  -  -  BU30  FDC  +  +  -  - 
BU32  CD21  +  +  -  - 
IOBla  CD21  +  +  -  -  Nonlineage 
MHM6  CD23  +  /  -  -  nt  2D1"  CD45  -  -  - 
$2C6  CD40  +  +  -  JC/70A*  CD31  -  -  - 
EBU141  CD75  +  +  -  F8/86"  Factor  VIII  -  -  - 
Adhesion molecules  B8.12.2  HLA-DR  +  +  -  - 
CLB-LFA1/2  CDlla  -  -  -  124"  BCL-2  -  +  +  - 
HP  2/1  CD49d  -  -  -  Ki67*  -  s  + s  +  + s 
R./R-1  CD54  +  +  +  +  -  MAS516  c~HuFB  +  +  +  +  + 
4B9  VCAM-1  +  +  -  -  Csl-4"  LMP-1  -  +  +  - 
Myeloid  associated  PE2*  EBNA-2  -  +  +  - 
CLB44  CD11b  +  -  - 
LeuM3  CD14  +  -  - 
CLB5D2  CD16  -  -  - 
2E1  CDw32  -  -  - 
D3  CD35  +  +  -  - 
Rating scale:  -,  negative;  +,  positive;  +  +,  strongly positive (arbitrary).  Abbreviation:  HFB,  human fibroblasts. 
* Determined on acetone fixed cytospins. 
* Determined on acetone/methanol (1:1)  fixed cytospins. 
S Only for Ki67 expression:  -,  negative;  +,  g10%  positive;  +  +,  I>10%  positive. 
Table  4.  Clustering  of B Cells to FLCL 
Percentage  of B  cells  in  cluster 
(percent  cells  apoptotic) 
Percentage  of B  cells  single 
(percent  cells  apoptotic) 
FLCL  HFB  FLCL  +  c~LFA  FLCL  HFB  FLCL  +  aLFA 
Expt.  1" 
LD  B  39  _+  4  (5  _+  3)  2  _+  2  (0)  2  _+  1(0)  61  +_  4  (85  _+  3)  98  _+  2  (82  _+  8) 
HDB  14_+  5  (2_+  4)  2  _+  2  (0)  3  -+  2(0)  86  _+  5  (74  _+  9)  98  _+  2  (76  _+  3) 
Expt.  2* 
LD  B  57  +  16  (3  +  4)  7  +  4  (0)  6  -+  1(0)  43  _+  16  (87  _+  6)  93  +  4  (83  -+  2) 
HDB  36  _+  8  (1  _+  2)  2  _+  2  (0)  3  +  1(0)  64  _+  8  (66  _+  10)  98  _+  2  (56  +  18) 
98  _+  1(85  _+  3) 
97  _+  2  (71  _+  12) 
94  _+  1(82  _+  4) 
97  _+  1(69  _+  15) 
Data are represented as mean  _+  SD for four micrographs taken after  18 h  of culture and 1 h  of Hoechst 33258 staining; each micrograph depicts 
at  least 150 lymphocytes. 
* Two representative experiments with different donors. Abbreviations: LD B, low density B cells; HD B, high density B cells; HFB, human fibroblasts. 
1180  Epstein-Barr Virus-transformed Follicular Dendritic Cells Figure  5.  Cultures of nonautologous tonsil B cells with (a and b) FI.CL or (c and d) human fibroblasts. Cultures were stained with Hoechst 33258. 
(a) Micrograph showing  B cells adhering very  closely  to FI.CL (arrows). (b) Fluorescence  picture showing that adhering cells are viable  (arrows), whereas 
nonadhering cells  remain loosely  accumulated  against the outline of the FLCL and are mainly apoptotic  as concluded  from the bright and dense staining 
of their sometimes fragmented nuclei (arrowheads). (c) Micrograph showing that B cells loosely  accumulate against the outline of human fibroblasts 
(arrows). (d) Fluorescence  picture showing that most B cells became apoptotic (arrowheads). (a and b)  x640; (c and d)  x320. 
of B cells to FLCL could be prevented with antibodies against 
LFA-1 (Table 4). This is in line with other reports (13, 31). 
Staining of cultures of FLCL and B cells with Hoechst 33258 
revealed that B cells binding to FLCL were prevented from 
apoptosis, whereas the vast majority of nonbinding cells dis- 
played an apoptotic appearance (84% of the nonbinding low- 
density B cells and 69%  of the high-density  B  cells)  (Fig. 
5 and Table 4). This has also been described for B cells ad- 
hering  to freshly isolated FDC  (13).  The  difference found 
in apoptotic cells between low-density and high-density B 
cells is in line with experiments done by other groups in which 
it was demonstrated that germinal center B cells, in contrast 
to mantle zone B cells, die rapidly by apoptosis upon culture 
in vitro (41,  42).  Furthermore  it was observed that  B  cell 
proliferation in vitro was inhibited if B cells were stimulated 
in the presence of FLCL and not in the presence of HFB (Table 
6). Part of the inhibitory effect of FLCL may be caused by 
soluble factors as the presence of FLCL-derived culture su- 
pernatants often resulted in decreased proliferation orb cells 
(Table 7). The nature of a putative inhibitory factor is presently 
unknown  but experiments  to reveal  this  are in progress. 
The data on the inhibitory effect of FLCL and Fig;L-culture 
1181  Lindhout  et al. Table  5.  Effect of FDC on B  Cell Proliferation 
Expt.  1  Expt.  2 
c~-/~ +  IL-2 stimulation 
FDC enriched 
FDC depleted 
SAC  +  IL-2 stimulation 
FDC enriched 
FDC depleted 
2,862  •  399 
7,204  _+  286 
15,734  _+  692 
22,328  •  1,113 
c~m 
12,456  +  2,777 
24,989  •  3,573 
11,860  _+  596 
31,752  +  2,295 
FDC-enricbed fractions (containing  _+  10% DRC-1 positive celts) were 
depleted from FDC by labeling with  BU30  mAb followed by goat 
anti-mouse  Ig-coated Dynabeads. The resulting population contained 
g1% DRC-1 positive cells. 2  x  104 cells/well were stimulated with 
immobilized anti-IgM (ce-/~) or SAC in the presence of 100 U/m1 IL-2. 
Results are shown from two independent experiments using cells derived 
from different donors. Data are mean +  SD from triplicate wells. 
supernatants are in line with previous experiments from our 
group using fleshly isolated  FDC  (Table 5)  and with  data 
of Freedman et al.  (33),  who also showed that freshly iso- 
lated  FDC  or  FDC  culture  supernatants  inhibit  B  cell 
proliferation. 
Previous studies in both the murine and human  system, 
however, have suggested that FDC-em'iched cell preparations 
may enhance B cell proliferation in vitro (32, 43-45).  These 
contrasting results may be explained as follows: in vivo, FDC 
mainly are present in the light zone of germinal centers.  In 
the dark zone of germinal centers, B cell proliferate very rap- 
idly while only few FDC with low ICAM-1 expression are 
present. In the basal part of the light zone FDC form a dense 
network of high ICAM-l-positive cells (3). During germinal 
center reactions, it is in this latter area that the rapid prolifer- 
ation of B cells is downregulated in close contact with FDC 
or in the close vicinity of FDC, suggesting an inhibitory effect 
of high ICAM-1 expressing FDC (which may be caused by 
soluble factors) on B  cell proliferation.  The present results 
therefore may reflect the  actions of high ICAM-l-positive 
FDC in the basal light zone. Alternatively,  the method for 
preparation  of FLCL used in this  study may have selected 
for FDC  that  can have a  downregulatory  effect on B  cell 
proliferation. 
With these FLCL we now have a helpful tool to unravel 
the functions of FDC in the processes of B cell differentia- 
tion  and  selection  of high-a~nity  antigen-specific B  cells. 
Table  6.  Effect of FLCL  on B  Cell Proliferation 
Expt.  1  Expt.  2  Expt.  3 
o~-/z  +  IL-2 
-  3,031  _+  611 
FLCL 361  547  +  82 
FLCL 369  1,457  _+  123 
FLCL 413 
FLCL 386 
HFB-VH (500/well)  2,001  _+  441 
HFB-VH (104/weU) 
SAC  +  IL-2 
-  10,252  _+ 348 
FLCL 361  536  _+  80 
FLCL 369  2,491  _+  167 
FLCL  413 
FLCL 386 
HFB-VH (500/well)  8,584  +  652 
HFB-VH (104/well) 
c~m 
1,281  _+  127 
603  _+  53 
890  +_  243 
1,352  +_  118 
4,806  +  89 
569  +  14 
1,925  +  337 
5,031  _+  528 
1,856  +  381 
1,576  •  129 
1,446  _+  32 
1,917  _+  191 
1,572  +  233 
6,984  _+  401 
3,504  +  270 
3,120  _+  390 
8,639  _+  1,028 
4,991  +  658 
Tonsillar B cells were stimulated in the presence or absence of 500 FLCL or HFB-VH per well. 2  x  104 cells/well were stimulated with immobi- 
lized anti-IgM (~-/~) or SAC in the presence of 100 U/ml IL-2. Results are shown from three independent experiments using cells derived from 
different donors. Data are mean _+ SD from triplicate wells. 
1182  Epstein-Barr  Virus-transformed Follicular Dendritic Cells Table  7.  Effect  of Supernatant of Cultured FLCL on B Cell Proliferation 
Expt.  1  Expt.  2  Expt.  3 
cpm 
or-#  +  IL-2 
-  1,516  _+  265  2,328  _+  218  2,660  _+  188 
+  sup 324  352  _+  107  1,396  +  315  1,134  _+  430 
+  sup 325  1,134  _+  389  3,028  +  599 
+  HFB supernatant  2,943  _+  229 
SAC  +  IL-2 
-  5,506  _+  306  7,156  _+  1,301  3,454  _+  322 
+  sup 324  1,308  +  198  2,682  +  145  844  _+  198 
+  sup 325  2,180  _+  548  3,964  _+  247 
+  HFB supernatant  2,918  _+  72 
B cells are stimulated in presence or absence of 50% FLCL or human fibroblast (HFB) culture supernatant.  2  x  104 cells/well were stimulated 
with immobilized anti-IgM (oe-#) or SAC in the presence of 100 U/ml IL-2. Results are shown from three independent experiments using cells 
derived from different donors. Data are cpm  +  SD from triplicate wells. 
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